Millipore price target upped by Merrill Lynch

Millipore Corp.'s stock price target was bumped up by Merrill Lynch & Co. to $61 from $58, with the rating reiterated its buy rating. Millipore, based in Billerica, Mass., is a bioscience company that designs and makes devices and tools used in biotech research. Millipore shares on Thursday slipped 14 cents, or 0.25%, to close at $56.70 on volume of 575,300 shares versus the three-month running average of 450,051.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.